While some of downregulated genes have been previously described as targets for cancer therapy such as asparaginase (Aspg)85, semaphorins (Sema3c)86, Adenosin A1 receptor (Adora1)87, phosphoenolpyruvate (Pck1)88, their association with immune responses are still largely unexplored. This evidence concerns the gene ADORA1 and cancer.